These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
788 related items for PubMed ID: 24704867
1. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Lega JC, Fabien N, Reynaud Q, Durieu I, Durupt S, Dutertre M, Cordier JF, Cottin V. Autoimmun Rev; 2014 Sep; 13(9):883-91. PubMed ID: 24704867 [Abstract] [Full Text] [Related]
2. Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition? Lega JC, Cottin V, Fabien N, Thivolet-Béjui F, Cordier JF. J Rheumatol; 2010 May; 37(5):1000-9. PubMed ID: 20231208 [Abstract] [Full Text] [Related]
6. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies. Dugar M, Cox S, Limaye V, Blumbergs P, Roberts-Thomson PJ. Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602 [Abstract] [Full Text] [Related]
7. Myositis-related interstitial lung disease and antisynthetase syndrome. Solomon J, Swigris JJ, Brown KK. J Bras Pneumol; 2011 Sep; 37(1):100-9. PubMed ID: 21390438 [Abstract] [Full Text] [Related]
8. Clinical characterisation of a multicentre nationwide cohort of patients with antisynthetase syndrome. Martins P, Dourado E, Melo AT, Samões B, Sousa M, Freitas R, Lourenço MH, Fernandes B, Costa E, Parente H, Martins F, Fonseca JE, Cordeiro I, Romão VC, Khmelinskii N, Campanilho-Marques R. ARP Rheumatol; 2022 Nov 01; 1(ARP Rheumatology, nº3 2022):190-196. PubMed ID: 35891592 [Abstract] [Full Text] [Related]
9. Heterogeneous clinical spectrum of interstitial lung disease in patients with anti-EJ anti-synthetase syndrome: a case series. Giannini M, Notarnicola A, Dastmalchi M, Lundberg IE, Lopalco G, Iannone F. Clin Rheumatol; 2016 Sep 01; 35(9):2363-7. PubMed ID: 27068736 [Abstract] [Full Text] [Related]
10. Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia. Yura H, Sakamoto N, Satoh M, Ishimoto H, Hanaka T, Ito C, Hasegawa T, Tanaka S, Miyamura T, Nakashima S, Hara A, Kakugawa T, Oda K, Kido T, Obase Y, Ishimatsu Y, Yatera K, Kawakami A, Mukae H. Respir Med; 2017 Nov 01; 132():189-194. PubMed ID: 29229096 [Abstract] [Full Text] [Related]
12. Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience. Zhang D, Wang H, Zhou X, Yang J, Liu Y, Wang W, Jiang P, Fan B. Immun Inflamm Dis; 2023 Nov 01; 11(11):e1085. PubMed ID: 38018600 [Abstract] [Full Text] [Related]
13. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy. Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EK. Clin Rev Allergy Immunol; 2017 Feb 01; 52(1):1-19. PubMed ID: 26424665 [Abstract] [Full Text] [Related]
14. Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification. Wu S, Xiao X, Zhang Y, Zhang X, Wang G, Peng Q. Ann Rheum Dis; 2024 May 15; 83(6):775-786. PubMed ID: 38395605 [Abstract] [Full Text] [Related]
15. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies. Fukamatsu H, Hirai Y, Miyake T, Kaji T, Morizane S, Yokoyama E, Hamada T, Oono T, Koyama Y, Norikane S, Iwatsuki K. J Dermatol; 2019 Oct 15; 46(10):886-897. PubMed ID: 31418479 [Abstract] [Full Text] [Related]
16. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Mahler M, Miller FW, Fritzler MJ. Autoimmun Rev; 2014 Oct 15; 13(4-5):367-71. PubMed ID: 24424190 [Abstract] [Full Text] [Related]